Proteomics strategies in cardiovascular research

Hans-Reinhard Zerkowski1, Thomas Grussenmeyer, Peter Matt

  • 1Division of Cardio-Thoracic Surgery, Kantonsspital Basel, Department of Research, University of Basel, Switzerland.

Insights

Proteomics research bridges genomics and physiology in cardiovascular disease. Analyzing heart tissue and animal models identifies protein sets to diagnose disease and predict therapy outcomes.

Area of Science:

  • Cardiovascular Research
  • Proteomics
  • Molecular Biology

Background:

  • Cardiovascular research has evolved from pathophysiology to receptor identification, signal transduction, and genetic mapping.
  • The human genome project has paved the way for molecular biological approaches in disease gene mapping.
  • Proteomics aims to connect genomic information with physiological research.

Purpose of the Study:

  • To utilize heart surgery specimens and animal models for proteomic data acquisition in cardiovascular research.
  • To identify co-regulated protein sets associated with specific cardiovascular disease states.
  • To define characteristic protein expression profiles for disease diagnosis and prognosis of therapeutic outcomes.

Main Methods:

  • Exploration of heart surgery specimens as a rich source for proteomic analysis.
  • Investigation of animal models of cardiovascular diseases and deficiencies.
  • Quantitative evaluation of proteomic components and comparison of detection methods (staining vs. biosynthetic labeling).

Main Results:

  • Feasibility studies demonstrate the potential for quantitative proteomic evaluation.
  • Identification of co-regulated protein sets involved in cardiovascular disease states.
  • Emphasis on defining characteristic protein expression profiles for diagnostic and prognostic purposes.

Conclusions:

  • Proteomics offers a powerful approach to bridge the gap between genomic and physiological understanding of cardiovascular diseases.
  • Analysis of protein expression patterns can aid in disease classification and predicting treatment efficacy.
  • Methodological considerations are crucial for accurate and comprehensive proteomic analysis in cardiovascular research.

Related Concept Videos

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...